Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07098403 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Trial of SHR-1905 in Subjects With Severe Uncontrolled Asthma

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Start date: Aug 13, 2025 to Sep 3, 2025v3
  2. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Aug 2025 to Aug 13, 2025 · Site details revisedv2 Show 2 more changesShow less
    • Start date changed from estimate of Aug 2025 to Aug 13, 2025
    • Site details revised
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is a phase III study of SHR-1905 in subjects with severe uncontrolled asthma. The purpose of the study is to evaluate efficacy and safety of SHR-1905 in subjects with severe uncontrolled asthma.
Trial Details
NCT Number NCT07098403
Lead Sponsor Guangdong Hengrui Pharmaceutical Co., Ltd
Conditions Asthma
Enrollment 408 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov